A single-center study of 11 patients with intraocular lymphoma treated with conventional chemotherapy followed by high-dose chemotherapy and autologous bone marrow transplantation in 5 cases

Leukemia and Lymphoma

Volumn 23, Issue 3-4, 1996, Pages 339-345

  Soussain, Carole ^a   Merle Béral, Hélène ^a   Reux, Isabelle ^a   Sutton, Laurent ^a   Fardeau, Christine ^a   Gerber, Sophie ^a   Othman, Tarek Ben ^a   Binet, Jacques Louis ^a   Lehoang, Phuc ^a   Leblond, Véronique ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Autologous bone marrow transplantation; Intraocular lymphoma; Polychemotherapy

Indexed keywords

BUSULFAN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; METHOTREXATE; METHYLPREDNISOLONE; THIOTEPA;

ADULT; AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; B CELL LYMPHOMA; BRAIN BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INTRAOCULAR TUMOR; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PATHOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; T CELL LYMPHOMA; VITRECTOMY;

EID: 12644304862     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054837     Document Type: Article

References (32)

1. Whitcup, S. M., De Smet, M. D., Rubin, B. I. et al. (1993) Intraocular Lymphoma. Ophtalmology, 100, 1399-1406.
2. Char, D. H., Ljung, B. M , Miller, T. et al. (1988) Primary intraocular lymphoma (ocular reticulum cell sarcoma) Diagnosis and management. Ophtalmology, 95, 625-630.
3. Char, D. H., Ljung, B. M., Deschènes, J. et al (1988) Intraocular lymphoma: immunological and cytological analysis. Br. J. Ophtalmol., 72, 905-911.
4. Freeman, L. N., Schachat, A. P., Knox, D. L. et al (1987) Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophtalmology, 94, 1631-1639
5. Rouwen, A. J. P., Wijermans, P. W., Boen-Tan, T. N. et al (1989) Intraocular non-Hodgkin's lymphoma treated with systemic and intrathecal chemotherapy and radiotherapy. A case report and review of the literature. Graefe's Arch. Clin. Exp. Ophtalmol., 221, 355-359.
6. Qualman, S. J., Mendelsohn, G., Mann, R. et al (1983) Intraocular lymphoma: Natural history based on a clinicopathologic study of eight cases and review of the literature. Cancer, 52, 878-886.
7. Cohen, I. J., Vogel, R., Matz, S et al (1986) Successful non-neurotoxic therapy (without radiation) of a multifocal primary brain lymphoma with a methotrexate, vincristine, and BCNU protocol (DEMOP). Cancer, 57, 6-11
8. Ervin, T. E., Canellos, G. (1980) Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexate. Cancer, 45, 1556-1557.
9. Siegel, M. J., Dalton, J., Friedman, A. H. et al (1989) Ten-year experience with primary ocular "reticulum cell sarcoma" (large cell non-Hodgkin's lymphoma). Br. J. Ophtalmol., 73, 342-346.
10. Peterson, K., Gordon, K. B., Heineman, M. H. et al (1993) The Clinical Spectrum of Ocular Lymphoma. Cancer, 72, 843-849.
11. Fine, H A., Mayer, R. J. (1993) Primary central nervous system lymphoma. Ann. Inter. Med., 119, 1093-1104.
12. DeAngelis, L., Yahalom, J., Thaler, H. T. et al (1992) Combined modality therapy for primary CNS lymphoma. J. Clin. Oncol., 10, 635-643.
13. Stauchen, J. A., Dalton, J., Friedman, A. H. (1989) Chemotherapy in the management of intraocular lymphoma. Cancer, 63, 1918-1921.
14. Velasquez, W. S., McLaughlm, P., Tucker, S. et al (1994) ESHAP: An effective chemotherapy regimen in refractory and relapsing lymphoma: a 4 year follow-up study. J. Clin. Oncol., 12, 1169-1176.
15. Berard, C. W., Greene, M. H., Jaffe, E S. et al (1881) A multidisciplinary approach to non-Hodskin's lymphomas. Ann. Inter. Med., 94, 218-235.
16. Blay, J. Y., Coiffier, B., Lasset, C. et al (1993) Role of chemotherapy in the treatment of primary cerebral lymphoma. Blood, 82, suppl 1-1533 (abst).
17. Neuwelt, E. A., Goldman, D L., Dahlborg, S. A. et al (1991) Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: Prolonged survival and preservetion of cognitive function. J. Clin. Oncol , 9, 1580-1590.
18. McLaughlin, P., Velasquez, W. S., Redman, J. R. et al (1988) Chemotherapy with dexamethasone, high-dose cytarabine, and cisplatin for parenchymal brain lymphoma. J. Natl. Cancer Inst., 80, 1408-1412.
19. Bauman, M. A., Ritch, P. S., Hande, K. R. et al (1986) Treatment of intraocular lymphoma with high-dose Ara-C. Cancer, 57, 1273-1275.
20. Stark-Vanes, V., Setser, A., Kohler, D. et al (1995) Combination chemotherapy in the treatment of primary central nervous system and intraocular lymphoma. Proc. Am. Soc. Clin. Oncol., 14, 306 (abstr).
21. Stewart, D J., Leavens, M., Maor, M. et al (1982) Human Central Nervous System Distribution of cis-Diamminedichloroplatinum and Use as a Radiosensitizer in Malignant Brain Tumors. Cancer Res., 42, 2474-2479.
22. Ott, R. J., Flower, M. A., Babish, J. W. et al (1991) Measurements of Blood-Brain Barrier Permeability in Patients Undergoing Radiotherapy and Chemotherapy for Primary Cerebral Lymphoma. Eur. J. Cancer, 27, 1356-1361.
23. Balis, F. M., Poplack, D G. (1989) Central Nervous System Pharmacology of Antileukemic Drugs. Am. J. Pediatr Hematol. Oncol., 11, 74-86.
24. DeAngelis, L. M. (1995) Current management of primary central nervous system lymphoma. Oncol., 9, 63-78.
25. Philip, T , Arrrutage, J. O., Spitzer, G. et al (1987) High-dose therapy and autologous bone marrow transplantation after conventional chemoterapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N. Engl. Med., 316, 1493-1498.
26. Lazarus, H. M., Crilley, P., Ciobanu, N. et al (1992) High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma. J. Clin. Oncol., 10, 1682-1689.
27. Ghosh, C., Lazarus, H. M., Hewlett, J. S. et al (1992) Fluctuation of serum phenytoin concentration during autologous bone marrow transplant for primary nervous system tumors. J. Neuro.-Oncol., 12, 25-32.
28. Schmidt, H., Henze, G., Borgmann, A. et al (1993) High dose busulfan (BU), VP-16 (VP), and thiotepa (TT) as preparative regimen for autologous bone marrow transplantation (ABMT) in high-risk ALL/NHL: A phase II study. Blood, 82, suupl 1:309 (abst).
29. Mukaiyama, T., Ogawa, M., Horikoshu, N. et al. (1990) High-dose cyclophosphamide, thio-TEPA, etoposide with autologous bone marrow transplantation for refractory cancers. Gan To Kagaku Ryako, 17, 2207-2211.
30. Przepiorka, D., Dimopoulos, M., Smith, T. et al (1994) Thiotepa, busulfan and cyclophosphamide as a preparative regimen for marrow transplantation: risk factors for early regimen-related toxicity. Ann. Hematol., 68, 183-188.
31. Heideman, R. L., Cole, D. E., Bahs, F. et al (1989) Phase I and Pharmacokinetics of Thiotepa in the cerebrospinal Fluid and in Plasma of Pediatric Patients: Evidence for Dose-dependent Plasma Clearance of Thiotepa. Cancer Res., 49, 736-741.
32. O'Dwyer, P. J., Engstrom, P. F., Cole, P. R. et al (1988) Phase I/pharmacokinetic reevaluation of thiotepa. Proc Am Soc. Clin. Oncol., 7, 64.